Resources
The latest in biomarkers research, from development and diagnostics to precision medicine
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers for Drug Discovery & Development
Immunoassays to bring your neurodegenerative therapeutics to market
Biomarkers for Clinical Development
Unveiling the Essential Criteria for Validating Clinical Biomarkers: A Comprehensive Guide
Biomarkers by Oxford Global will explore the essential criteria for validating clinical biomarkers, shedding light on the steps and challenges involved.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Diagnostics
Early Diagnostic Blood Biomarker for Dementia Identified Using Proteomics
The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.
Diagnostics
Investigating Biases in Diagnostics and Biomarkers: Three Case Studies
In the quest to improve diagnostics, new technologies are key, but so is overcoming entrenched bias.
Diagnostics
Machine Learning Metabolomics Approach Used to Diagnose Ovarian Cancer
Researchers have used an artificial intelligence model to analyse the metabolites of patients with or without ovarian cancer and have reported shocking accuracy of diagnosis.
Digital Biomarkers & Digital Pathology
Enhancing Patient Care: Exploring the Role of Digital Biomarkers in Patient-Centric Healthcare
Digital biomarkers, collected from wearables and apps, are reshaping patient-centered healthcare with real-time insights and personalized care. Challenges like data privacy and interoperability require collaboration between healthcare, tech, and regulators for full integration.
Diagnostics
Using Biosensors for Biomarker Identification and Validation in Lung Cancer
Advancements in biosensors, notably graphene-based ones, show promise in swiftly identifying elusive lung cancer biomarkers, potentially revolutionising early diagnosis.
Biomarkers for Clinical Development
Advancing Biomarkers and Diagnostics in Diabetes Clinical Trials
Here, we speak to Matthias von Herrath about Biomarkers US 2023 and some current trends in the industry concerning research and technological development.
Biomarkers for Clinical Development
In Conversation With... Shuang Liang, Assistant Professor at UT Southwestern Medical Centre
Here, we speak to UT Southwestern’s Shuang Liang about monitoring TREM2 as a non-invasive diagnostic biomarker for NASH.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers